Company Filing History:
1 out of 19 
1 out of 5,089 
1 out of 38 Years Active: 2020
Title: Innovations by Miklós Képiró: Pioneering Water-Soluble Myosin Inhibitors
Introduction: Miklós Képiró, an inventive mind from Siklos, Hungary, has made significant strides in the field of pharmaceutical sciences. With a focus on neurological, neuropathic, and psychiatric diseases, Képiró has contributed to the scientific community through his innovative patent concerning water-soluble myosin 2 inhibitors.
Latest Patents: Képiró's notable patent, titled "Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases," introduces highly soluble, non-fluorescent, and photostable myosin inhibitors. This invention emphasizes the in vivo inhibition of the ATPase activity of neuronal non-muscle myosin 2. The patent also covers pharmaceutical compositions that incorporate these compounds along with the processes for their manufacturing and their intermediates.
Career Highlights: Throughout his career, Miklós Képiró has been associated with prestigious institutions such as Paris Sciences et Lettres and Centre National De La Recherche Scientifique. His work at these institutions has facilitated significant advancements in the understanding and treatment of various neurological conditions.
Collaborations: Képiró has collaborated with esteemed colleagues like Zsolt Lenkei and András Málnási Csizmadia, contributing to a rich exchange of ideas and fostering innovative research in their field.
Conclusion: Miklós Képiró continues to exemplify the essence of innovation through his work on water-soluble myosin inhibitors. His contributions not only hold the potential to revolutionize treatments for neurological and psychiatric diseases but also inspire future research within the pharmaceutical landscape.